KYTX vs. HOOD
KYTX (Kyverna Therapeutics, Inc) and HOOD (Robinhood Markets, Inc.) are both stocks. KYTX operates in Biotechnology (Healthcare), while HOOD operates in Software - Infrastructure (Technology). Over the past year, KYTX returned 180.29% vs 15.52% for HOOD. At a 0.28 correlation, their price movements are largely independent.
Performance
KYTX vs. HOOD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KYTX achieves a -16.81% return, which is significantly higher than HOOD's -26.75% return.
KYTX
- 1D
- -1.01%
- 1M
- -13.11%
- YTD
- -16.81%
- 6M
- 8.91%
- 1Y
- 180.29%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HOOD
- 1D
- -6.02%
- 1M
- 8.23%
- YTD
- -26.75%
- 6M
- -38.01%
- 1Y
- 15.52%
- 3Y*
- 107.01%
- 5Y*
- —
- 10Y*
- —
KYTX vs. HOOD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
KYTX Kyverna Therapeutics, Inc | -16.81% | 151.34% | -87.53% |
HOOD Robinhood Markets, Inc. | -26.75% | 203.54% | 232.09% |
Correlation
The correlation between KYTX and HOOD is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Feb 9, 2024 | 0.28 |
Fundamentals
KYTX:
$472.60M
HOOD:
$75.81B
KYTX:
-$3.22
HOOD:
$2.07
KYTX:
2.42
HOOD:
7.83
KYTX:
$0.00
HOOD:
$3.91B
KYTX:
-$1.30M
HOOD:
$2.86B
KYTX:
-$158.20M
HOOD:
$1.80B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KYTX vs. HOOD — Risk / Return Rank
KYTX
HOOD
KYTX vs. HOOD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kyverna Therapeutics, Inc (KYTX) and Robinhood Markets, Inc. (HOOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KYTX | HOOD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.69 | 0.23 | +1.46 |
Sortino ratioReturn per unit of downside risk | 2.42 | 0.83 | +1.59 |
Omega ratioGain probability vs. loss probability | 1.30 | 1.10 | +0.20 |
Calmar ratioReturn relative to maximum drawdown | 5.02 | 0.27 | +4.75 |
Martin ratioReturn relative to average drawdown | 10.28 | 0.50 | +9.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KYTX | HOOD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.69 | 0.23 | +1.46 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.45 | 0.27 | -0.71 |
Drawdowns
KYTX vs. HOOD - Drawdown Comparison
The maximum KYTX drawdown since its inception was -93.92%, roughly equal to the maximum HOOD drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for KYTX and HOOD.
Loading charts...
Drawdown Indicators
| KYTX | HOOD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.92% | -90.21% | -3.71% |
Max Drawdown (1Y)Largest decline over 1 year | -36.14% | -57.26% | +21.12% |
Max Drawdown (3Y)Largest decline over 3 years | — | -57.26% | — |
Current DrawdownCurrent decline from peak | -74.02% | -45.66% | -28.36% |
Average DrawdownAverage peak-to-trough decline | -73.18% | -60.99% | -12.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.61% | 30.88% | -13.27% |
Volatility
KYTX vs. HOOD - Volatility Comparison
Kyverna Therapeutics, Inc (KYTX) and Robinhood Markets, Inc. (HOOD) have volatilities of 22.01% and 21.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KYTX | HOOD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.01% | 21.14% | +0.87% |
Volatility (6M)Calculated over the trailing 6-month period | 74.25% | 50.03% | +24.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 107.69% | 68.61% | +39.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 99.25% | 73.99% | +25.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.25% | 73.99% | +25.26% |
Dividends
KYTX vs. HOOD - Dividend Comparison
Neither KYTX nor HOOD has paid dividends to shareholders.
Financials
KYTX vs. HOOD - Financials Comparison
This section allows you to compare key financial metrics between Kyverna Therapeutics, Inc and Robinhood Markets, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KYTX and HOOD have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KYTX has higher volatility (22.01%) compared to HOOD (21.14%). In terms of maximum drawdown, KYTX dropped -93.92% vs HOOD's -90.21%.
KYTX currently has the higher Sharpe Ratio (1.69 vs 0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KYTX and HOOD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer